ConductScience.org, home

Paper25976012

Factor XI and contact activation as targets for antithrombotic therapy.

Gailani D and 2 others. J Thromb Haemost, 2015. Cited by 111 papers, by iCite.

Cite this record

ConductScience Library. Factor XI and contact activation as targets for antithrombotic therapy. Papers, record 25976012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25976012

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Factor XI and contact activation as targets for antithrombotic therapy.
PubMed
Journal
J Thromb Haemost
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Review
PubMed
Citations, by iCite
111
iCite
Relative citation ratio, by iCite
4.24
iCite
Revised in PubMed
2024-06-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gailani DD
2Bane CEC E
3Gruber AA

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnticoagulantsMajor topic
Blood CoagulationMajor topic
Factor XIMajor topic
Factor XIIMajor topic
Fibrinolytic AgentsMajor topic
Venous ThrombosisMajor topic
Animals
Disease Models, Animal
Drug Design
Enzyme Activation
Hemorrhage
Humans
Molecular Targeted Therapy
Risk Factors
Treatment Outcome

Source PubMed

Download CSV of topics

Grants17

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
HL58837NHLBI NIH HHSUnited StatesR01HL058837PubMed and NIHNIH RePORTER
HL101972NHLBI NIH HHSUnited StatesR01HL101972PubMed and NIHNIH RePORTER
UL1TR000128NCATS NIH HHSUnited StatesUL1TR000128PubMed and NIHNIH RePORTER
K01 RR000163NCRR NIH HHSUnited StatesP06RR000163PubMed and NIHNIH RePORTER
RR000163NCRR NIH HHSUnited StatesP06RR000163PubMed and NIHNIH RePORTER
AI088937NIAID NIH HHSUnited StatesR43AI088937PubMed and NIHNIH RePORTER
R01 HL081326NHLBI NIH HHSUnited StatesR01HL081326PubMed and NIHNIH RePORTER
UL1 TR000128NCATS NIH HHSUnited StatesUL1TR000128PubMed and NIHNIH RePORTER
P51 RR000163NCRR NIH HHSUnited StatesP06RR000163PubMed and NIHNIH RePORTER
R44 AI088937NIAID NIH HHSUnited StatesR43AI088937PubMed and NIHNIH RePORTER
R43 AI088937NIAID NIH HHSUnited StatesR43AI088937PubMed and NIHNIH RePORTER
HL81326NHLBI NIH HHSUnited StatesR01HL081326PubMed and NIHNIH RePORTER
R01 HL058837NHLBI NIH HHSUnited StatesR01HL058837PubMed and NIHNIH RePORTER
R01 HL101972NHLBI NIH HHSUnited StatesR01HL101972PubMed and NIHNIH RePORTER
P40RR000163NIHNIH RePORTER
P51RR000163NIHNIH RePORTER
R44AI088937NIHNIH RePORTER

Download CSV of grants

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119617576Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology.Blood2009https://conductscience.org/library/papers/19617576PubMed
221527525Activation of factor XI by products of prothrombin activation.Blood2011https://conductscience.org/library/papers/21527525PubMed
319534693Recent developments in thrombin-activatable fibrinolysis inhibitor research.Mini Rev Med Chem2009https://conductscience.org/library/papers/19534693PubMed
420798043Extracellular DNA traps promote thrombosis.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20798043PubMed
524018259Secondary prevention of venous thromboembolism.BMJ2013https://conductscience.org/library/papers/24018259PubMed
625696834Future prospects for contact factors as therapeutic targets.Hematology Am Soc Hematol Educ Program2014https://conductscience.org/library/papers/25696834PubMed
721828145Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin.Blood2011https://conductscience.org/library/papers/21828145PubMed
825202141Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis.Blood2014https://conductscience.org/library/papers/25202141PubMed
925696835Recent insights into the role of the contact pathway in thrombo-inflammatory disorders.Hematology Am Soc Hematol Educ Program2014https://conductscience.org/library/papers/25696835PubMed
1020723033A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty.J Thromb Haemost2010https://conductscience.org/library/papers/20723033PubMed
11270705Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/270705PubMed
1218491973Survival advantage of coagulation factor XI-deficient mice during peritoneal sepsis.J Infect Dis2008https://conductscience.org/library/papers/18491973PubMed
1312689935Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates.Blood2003https://conductscience.org/library/papers/12689935PubMed
1424152424Evidence for factor IX-independent roles for factor XIa in blood coagulation.J Thromb Haemost2013https://conductscience.org/library/papers/24152424PubMed
1517405864Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17405864PubMed
1622442348Inhibition of factor XI activation attenuates inflammation and coagulopathy while improving the survival of mouse polymicrobial sepsis.Blood2012https://conductscience.org/library/papers/22442348PubMed
1718217146Factor XIa and tissue factor activity in patients with coronary artery disease.Thromb Haemost2008https://conductscience.org/library/papers/18217146PubMed
1824759141Physiologic activities of the contact activation system.Thromb Res2014https://conductscience.org/library/papers/24759141PubMed
1910706899High levels of coagulation factor XI as a risk factor for venous thrombosis.N Engl J Med2000https://conductscience.org/library/papers/10706899PubMed
2020709905Polyphosphate exerts differential effects on blood clotting, depending on polymer size.Blood2010https://conductscience.org/library/papers/20709905PubMed

See all 91 referencesDownload CSV of references

Cited by62

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 111 citations.

PMIDTitleJournalYearIn PapersSource
40969896The Discovery of a Novel Anticoagulant Mechanism: Factor XI Activation Inhibitors.ACS Pharmacol Transl Sci2025https://conductscience.org/library/papers/40969896PubMed
40045992Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults.Drug Des Devel Ther2025https://conductscience.org/library/papers/40045992PubMed
39852436The Role of Rotational Thromboelastometry in Early Detection of the Hemostatic Derangements in Neonates with Systemic Candida Infection.J Fungi (Basel)2024https://conductscience.org/library/papers/39852436PubMed
39262322Catheter-related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs.Eur J Clin Invest2025https://conductscience.org/library/papers/39262322PubMed
39077577Abelacimab in Cancer-Associated Thrombosis: The Right Drug at the Right Time for the Right Purpose. A Comprehensive Review.Rev Cardiovasc Med2023https://conductscience.org/library/papers/39077577PubMed
39073551Therapeutic Potential of FXI Inhibitors: Hype or Hope?Drugs2024https://conductscience.org/library/papers/39073551PubMed
39025971Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants.Sci Rep2024https://conductscience.org/library/papers/39025971PubMed
38779744Novel horizons in anticoagulation: the emerging role of factor XI inhibitors across different settings.Haematologica2024https://conductscience.org/library/papers/38779744PubMed
38257286Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa.Molecules2024https://conductscience.org/library/papers/38257286PubMed
38238638Brain development in newborns and infants after ECMO.World J Pediatr2024https://conductscience.org/library/papers/38238638PubMed
38193071Factors XI and XII in extracorporeal membrane oxygenation: longitudinal profile in children.Res Pract Thromb Haemost2023https://conductscience.org/library/papers/38193071PubMed
37970718Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial.Arterioscler Thromb Vasc Biol2024https://conductscience.org/library/papers/37970718PubMed
37568292Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis.J Clin Med2023https://conductscience.org/library/papers/37568292PubMed
37522956Anticoagulation in the ICU: a future for contact pathway inhibition?Intensive Care Med2023https://conductscience.org/library/papers/37522956PubMed
37169875New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022.Eur Heart J Cardiovasc Pharmacother2023https://conductscience.org/library/papers/37169875PubMed
37101592Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous Thrombosis.TH Open2023https://conductscience.org/library/papers/37101592PubMed
37063763Combined oral contraceptives may activate the contact system in healthy women.Res Pract Thromb Haemost2023https://conductscience.org/library/papers/37063763PubMed
36898159Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma.J Med Chem2023https://conductscience.org/library/papers/36898159PubMed
36583671A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation.Blood Adv2023https://conductscience.org/library/papers/36583671PubMed
36547434Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular Disease.J Cardiovasc Dev Dis2022https://conductscience.org/library/papers/36547434PubMed

See all 62 cited byDownload CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25976012

GET https://conductscience.org/api/papers/v1/25976012/references?page=2